PUBLISHER: The Business Research Company | PRODUCT CODE: 1425518

PUBLISHER: The Business Research Company | PRODUCT CODE: 1425518

H1N1 Vaccine Global Market Report 2024

Published: Pre-Order

PAGES: 200 Pages

DELIVERY TIME: 2-10 business days

ADD TO COMPARE

SELECT AN OPTION

Description

H1N1 Vaccine Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on h1n1 vaccine market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for h1n1 vaccine? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The h1n1 vaccine market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

1) By Product Type: Inactivated Vaccine; Live Attenuated Vaccine
2) By Route Of Administration: Intradermal Vaccination; Intramuscular Vaccination; Subcutaneous Vaccination
3) By End Users: Hospitals; Clinics; Research and Diagnostic Laboratories; Other End Users
Companies Mentioned: Sanofi SA; Novartis AG; GlaxoSmithKline PLC; CSL Limited; AstraZeneca Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

H1N1 vaccines are designed for individuals aged six months and older to guard against influenza triggered by the H1N1 2009 virus. These vaccines work by introducing a small, weakened dose of the virus into the body, stimulating the immune system to build protection against the virus.

The primary product types for H1N1 vaccines include inactivated and live attenuated vaccines. Inactivated vaccines within the market are formulated to prevent diseases caused by the influenza H1N1 virus. They consist of synthetic vaccines with protective immunizing properties, containing hemagglutinin (HA) antigens derived from four inactivated influenza viruses, encompassing two distinct influenza type A strains and two different influenza type B strains. These vaccines are administered through various routes such as intradermal, intramuscular, and subcutaneous methods, and they are utilized across hospitals, clinics, research and diagnostic laboratories, among other medical settings.

The H1N1 vaccine market report is one of a series of new reports from The Business Research Company that provides H1N1 vaccine market statistics, including H1N1 vaccine industry global market size, regional shares, competitors with an H1N1 vaccine market share, detailed H1N1 vaccine market segments, market trends and opportunities, and any further data you may need to thrive in the H1N1 vaccine industry. This H1N1 vaccine market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The h1n1 vaccine market size has grown strongly in recent years. It will grow from $3.16 billion in 2023 to $3.37 billion in 2024 at a compound annual growth rate (CAGR) of 6.8%. Historical growth can be attributed to past influenza outbreaks, heightened concerns about global health security, advancements in vaccine development and approval processes, the implementation of global vaccination campaigns, educational initiatives for public health, government funding and subsidies, and the pharmaceutical industry's adaptability and responsiveness.

The H1N1 vaccine market size is expected to see strong growth in the next few years. It will grow to $4.46 billion in 2028 at a compound annual growth rate (CAGR) of 7.2%. The anticipated growth in the forecast period is driven by research into broad-spectrum vaccines, initiatives aimed at global vaccine equity, efforts to build resilience in public health systems, strengthening global health governance, and the integration of H1N1 vaccination with routine immunization programs. Major trends expected during this period encompass preparedness for global pandemics, ongoing influenza vaccination programs, advancements in vaccine development, research into cross-protection, global health initiatives, technological improvements in vaccine manufacturing, expansion of production capacities, and the enhancement of data monitoring and surveillance within the field of vaccination and public health.

Increased expenditure in immunology and vaccine R&D is driving H1N1 vaccine market growth. Immunology and vaccines, integral in preventing infections and bolstering antibody production, receive significant research focus. Notably, global governments invested $94.11 billion (€93 billion) in vaccine and treatment development within 11 months since the pandemic onset, with 95% coming from the public sector, primarily allocated to vaccination development, fostering the H1N1 vaccine market.

The surge in international travel is a catalyst for the H1N1 vaccine market. International travel, involving cross-border movement for tourism, business, and more, demands H1N1 vaccination as a preventive measure. Nations and global bodies recommend or mandate H1N1 vaccination to curb virus transmission during travel. International tourism receipts hitting $1 trillion in 2022 and reaching 64% of pre-pandemic levels signify the market's growth fueled by increased travel safety measures.

Strategic collaborations are shaping the H1N1 vaccine market landscape. Companies forge partnerships to amplify market presence. An example is the $123 million agreement between A significant and hVIVO to create an H1N1 influenza challenge virus, boosting growth potential for both entities in the industry.

Innovations like needle-free nasal vaccines propel the H1N1 vaccine market. Needle-free nasal vaccines, devoid of traditional needles or syringes, offer a painless, non-invasive immunization method, predominantly through nasal administration. Nasovac S4, launched by Serum Institute and Mylab in October 2023, targets H1N1 and H3N2 viruses, stimulating immune response in individuals aged 2 and above against influenza strains A and B, underscoring market sustainability and product advancements.

In July 2023, Sinovac Biotech Ltd., a prominent biopharmaceutical company based in China, forged a strategic partnership with Bio Farma, a state-owned biopharmaceutical company based in Indonesia, for an undisclosed investment. This alliance is designed to cater to Indonesia's domestic vaccine market while targeting expansion into the international sphere. The collaboration between Sinovac and Bio Farma is aimed at facilitating Sinovac's introduction of upcoming products, such as varicella, influenza, and pneumococcal polysaccharide vaccines. These initiatives are intended to address the healthcare needs of the region effectively and contribute to the enhancement of local and national public health initiatives. Bio Farma is an Indonesia-based state-owned biopharmaceutical company, operating in various vaccine markets, including H1N1.

Major companies operating in the h1n1 vaccine market report are Sanofi SA, Novartis AG, GlaxoSmithKline PLC, CSL Limited, AstraZeneca Inc., Zydus Lifesciences Limited, Merck and Co.Inc., Novavax Inc., Baxter Laboratories Inc., Panacea Biotec Ltd., Sinovac Biotech Ltd., Green Cross Corp., Abbott Laboratories, Pfizer Inc., Mitsubishi Tanabe Pharma Corporation, Seqirus Ltd., Cipla Inc., Protein Sciences Corporation, Hualan Biological Engineering Inc., Changsheng Bio-Technology Co. Ltd., Takeda Pharmaceutical Ltd., Bharat Biotech International Limited, Serum Institute of India Pvt. Ltd., Bio Farma Group, PT Kalbe Farma Tbk, Daiichi Sankyo Chemical Pharma Co. Ltd., Johnson & Johnson Services Inc., F. Hoffmann-La Roche Ltd., Moderna Inc., CureVac NV, BioNTech SE, Inovio Pharmaceuticals Inc., Vaxart Inc., Altimmune Inc., Dynavax Technologies Corporation, VBI Vaccines Inc., and GeoVax Labs Inc.

North America was the largest region in the H1N1 vaccine market in 2023. The regions covered in the h1n1 vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the h1n1 vaccine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The H1N1 vaccines market consists of sales of TIV (flu shot (injection) and LAIV (nasal spray (mist) of live attenuated influenza vaccine). Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Product Code: r12749

1. Executive Summary

2. H1N1 Vaccine Market Characteristics

3. H1N1 Vaccine Market Trends And Strategies

4. H1N1 Vaccine Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market

5. Global H1N1 Vaccine Market Size and Growth

5.1. Global H1N1 Vaccine Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global H1N1 Vaccine Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global H1N1 Vaccine Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. H1N1 Vaccine Market Segmentation

6.1. Global H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Inactivated Vaccine
Live Attenuated Vaccine
6.2. Global H1N1 Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Intradermal Vaccination
Intramuscular Vaccination
Subcutaneous Vaccination
6.3. Global H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Hospitals
Clinics
Research and Diagnostic Laboratories
Other End Users

7. H1N1 Vaccine Market Regional And Country Analysis

7.1. Global H1N1 Vaccine Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global H1N1 Vaccine Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific H1N1 Vaccine Market

8.1. Asia-Pacific H1N1 Vaccine Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific H1N1 Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China H1N1 Vaccine Market

9.1. China H1N1 Vaccine Market Overview
9.2. China H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China H1N1 Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India H1N1 Vaccine Market

10.1. India H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India H1N1 Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan H1N1 Vaccine Market

11.1. Japan H1N1 Vaccine Market Overview
11.2. Japan H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan H1N1 Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia H1N1 Vaccine Market

12.1. Australia H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia H1N1 Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia H1N1 Vaccine Market

13.1. Indonesia H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia H1N1 Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea H1N1 Vaccine Market

14.1. South Korea H1N1 Vaccine Market Overview
14.2. South Korea H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea H1N1 Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe H1N1 Vaccine Market

15.1. Western Europe H1N1 Vaccine Market Overview
15.2. Western Europe H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe H1N1 Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK H1N1 Vaccine Market

16.1. UK H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK H1N1 Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany H1N1 Vaccine Market

17.1. Germany H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany H1N1 Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France H1N1 Vaccine Market

18.1. France H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France H1N1 Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy H1N1 Vaccine Market

19.1. Italy H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy H1N1 Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain H1N1 Vaccine Market

20.1. Spain H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain H1N1 Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe H1N1 Vaccine Market

21.1. Eastern Europe H1N1 Vaccine Market Overview
21.2. Eastern Europe H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe H1N1 Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia H1N1 Vaccine Market

22.1. Russia H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia H1N1 Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America H1N1 Vaccine Market

23.1. North America H1N1 Vaccine Market Overview
23.2. North America H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America H1N1 Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA H1N1 Vaccine Market

24.1. USA H1N1 Vaccine Market Overview
24.2. USA H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA H1N1 Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada H1N1 Vaccine Market

25.1. Canada H1N1 Vaccine Market Overview
25.2. Canada H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada H1N1 Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America H1N1 Vaccine Market

26.1. South America H1N1 Vaccine Market Overview
26.2. South America H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America H1N1 Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil H1N1 Vaccine Market

27.1. Brazil H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil H1N1 Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East H1N1 Vaccine Market

28.1. Middle East H1N1 Vaccine Market Overview
28.2. Middle East H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East H1N1 Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa H1N1 Vaccine Market

29.1. Africa H1N1 Vaccine Market Overview
29.2. Africa H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa H1N1 Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. H1N1 Vaccine Market Competitive Landscape And Company Profiles

30.1. H1N1 Vaccine Market Competitive Landscape
30.2. H1N1 Vaccine Market Company Profiles
- 30.2.1. Sanofi SA
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. Novartis AG
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. GlaxoSmithKline plc
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. CSL Limited
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. AstraZeneca Inc.
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Global H1N1 Vaccine Market Competitive Benchmarking

32. Global H1N1 Vaccine Market Competitive Dashboard

33. Key Mergers And Acquisitions In The H1N1 Vaccine Market

34. H1N1 Vaccine Market Future Outlook and Potential Analysis

34.1 H1N1 Vaccine Market In 2028 - Countries Offering Most New Opportunities
34.2 H1N1 Vaccine Market In 2028 - Segments Offering Most New Opportunities
34.3 H1N1 Vaccine Market In 2028 - Growth Strategies
- 34.3.1 Market Trend Based Strategies
- 34.3.2 Competitor Strategies

35. Appendix

35.1. Abbreviations
35.2. Currencies
35.3. Historic And Forecast Inflation Rates
35.4. Research Inquiries
35.5. The Business Research Company
35.6. Copyright And Disclaimer

Have a question?

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Christine Sirois

Manager - Americas

+1-860-674-8796

SEE OUR FAQ